Teknova Reports Third Quarter 2025 Financial Results Third quarter 2025 total revenue was $10.5 million, up 9$39-42 million HOLLISTER, Calif., November 6, 2025 – Alpha Teknova, Inc. ("Teknova" or the "Company") (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today ...